传染病建模(英文)(Infectious Disease Modelling)(可官网投稿)

《传染病建模(英文)》(Infectious Disease Modelling)(季刊),杂志于2016年创办,经新闻出版总署批准的正规刊物,2021年获批国家统一连续出版物号,是一份经过同行评审的开放获取期刊,旨在促进数学建模、传染病数据检索和分析以及公共卫生决策支持方面的研究工作。

本刊特点:CSCD核心期刊(2023-2024),目次收录(维普),目次收录(知网),外文期刊,

传染病建模(英文)(Infectious Disease Modelling)

期刊基本信息

出版周期:季刊 级别:核心期刊
主管部门:中国科学院
主办单位:中国科技出版传媒股份有限公司
编辑部:《传染病建模(英文)》编辑部
中国国内刊号:CN10-1766/R
国际标准刊号:ISSN 2468-2152;EISSN 2468-0427

杂志社联系方式

地址:北京市东黄城根北街16号
邮编:100717
电话:001-64015921
官网邮箱:wendy.ye@keaipublishing.com
官方网站:http://www.keaipublishing.com/en/journals/infectious-disease-modelling/

杂志征稿投稿要求

《传染病建模(英文)》期刊信息

【微信公众号“科爱出版”信息】

2021-01-07

欢迎楼一均、何岱海担任Infectious Disease Modelling新副主编!

2020年,Infectious Disease Modelling(IDM)被ESCI收录,同时入选2020年中国科技期刊卓越行动计划高起点新刊项目。

2020年,IDM积极组织并发表关于新型冠状病毒研究成果的特刊,所有文章及时发表在ScienceDirect上,接受下载和引用,推动科学研究。

感谢大家对期刊发展的支持与贡献,IDM主编、副主编及全体编委成员祝大家新年快乐,在新的一年里希望大家一如既往地支持并投稿IDM。

2021年,Infectious Disease Modelling(IDM)迎来了两位新任副主编:楼一均博士,香港理工大学应用数学系副教授;何岱海博士,香港理工大学应用数学系副教授。热烈欢迎两位副教授担任IDM副主编。

Infectious Disease Modelling

Infectious Disease Modelling (IDM)是一份经过同行评审的开放获取期刊,旨在促进数学建模、传染病数据检索和分析以及公共卫生决策支持方面的研究工作。

文章收录内容主要包括:

– Developing new frameworks, models and methodologies including comparisons with existing models, theories and methods to indicate demonstrable advantages;

– Applications of exiting models and methodologies to new infectious diseases and/or public health issues;

– Integrative use of methodologies and interdisciplinary approaches to evaluate intervention programs and to inform surveillance design;

-Developing linkages between data, modelling, analytics and policy.

期刊目前已被DOAJ、ESCI、Embase、PubMed Central、Scopus 收录,并且已经提交了MEDLINE申请,正在接受评估。入选2020年中国科技期刊卓越行动计划高起点新刊项目。所有文章均可在ScienceDirect免费下载阅读。

欢迎投稿

IDM诚挚地邀请相关领域的学者关注期刊并投稿,所有文章将经过严格的同行评审,一经收录将在ScienceDirect平台免费开放获取。

投稿网址:www.editorialmanager.com/IDM

投稿前请仔细阅读“作者指南”。

《传染病建模(英文)》作者指南

【杂志社官方网站信息】

Guide for Authors

INTRODUCTION

Types of paper

Contributions falling into the following categories will be considered for publication: Original Research Papers, Reviews, Short Communications.

Please ensure that you select the appropriate article type from the list of options when making your submission. Authors contributing to special issues should ensure that they select the special issue article type from this list.

Submission checklist

You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in this Guide for Authors for more details.

Ensure that the following items are present:

One author has been designated as the corresponding author with contact details:

• E-mail address

• Full postal address

All necessary files have been uploaded:

Manuscript:

• Include keywords

• All figures (include relevant captions)

• All tables (including titles, description, footnotes)

• Ensure all figure and table citations in the text match the files provided

• Indicate clearly if color should be used for any figures in print

Graphical Abstracts / Highlights files (where applicable)

Supplemental files (where applicable)

Further considerations

• Manuscript has been 'spell checked' and 'grammar checked'

• All references mentioned in the Reference List are cited in the text, and vice versa

• Permission has been obtained for use of copyrighted material from other sources (including the Internet)

• A competing interests statement is provided, even if the authors have no competing interests to declare

• Journal policies detailed in this guide have been reviewed

• Referee suggestions and contact details provided, based on journal requirements

For further information, visit our Support Center.

BEFORE YOU BEGIN

Ethics approval and consent to participate

Manuscripts reporting studies involving human participants, human data or human tissue must:

include a statement on ethics approval and consent (even where the need for approval was waived)

include the name of the ethics committee that approved the study and the committee's reference number if appropriate

All materials must adhere to high ethical and animal welfare standards. Any use of animals must be based on ethological knowledge and respect for species-specific requirements for health and well-being. A statement indicating that the protocol and procedures employed were ethically reviewed and approved, and the name of the body giving approval, must be included in the Methods section of the manuscript.

Consent for publication:

If your research or manuscript contains any individual person's data in any form (including any individual details, images or videos), consent for publication must be obtained from that person, or in the case of children, their parent or legal guardian. All presentations of case reports must have consent for publication.

Declaration of competing interest

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors should complete the declaration of competing interest statement using this template and upload to the submission system at the Attach/Upload Files step. Note: Please do not convert the .docx template to another file type. Author signatures are not required. If there are no interests to declare, please choose the first option in the template. More information.

Submission declaration and verification

Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis, see 'Multiple, redundant or concurrent publication' for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To verify originality, your article may be checked by the originality detection service Crossref Similarity Check.

Use of inclusive language

Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Content should make no assumptions about the beliefs or commitments of any reader; contain nothing which might imply that one individual is superior to another on the grounds of age, gender, race, ethnicity, culture, sexual orientation, disability or health condition; and use inclusive language throughout. Authors should ensure that writing is free from bias, stereotypes, slang, reference to dominant culture and/or cultural assumptions. We advise to seek gender neutrality by using plural nouns ("clinicians, patients/clients") as default/wherever possible to avoid using "he, she," or "he/she." We recommend avoiding the use of descriptors that refer to personal attributes such as age, gender, race, ethnicity, culture, sexual orientation, disability or health condition unless they are relevant and valid. These guidelines are meant as a point of reference to help identify appropriate language but are by no means exhaustive or definitive.

Author contributions

For transparency, we encourage authors to submit an author statement file outlining their individual contributions to the paper using the relevant CRediT roles: Conceptualization; Data curation; Formal analysis; Funding acquisition; Investigation; Methodology; Project administration; Resources; Software; Supervision; Validation; Visualization; Roles/Writing – original draft; Writing – review & editing. Authorship statements should be formatted with the names of authors first and CRediT role(s) following. More details and an example

……

更多详情:

http://www.keaipublishing.com/en/journals/infectious-disease-modelling/guide-for-authors/

刊知网 精心整理,转载请注明出处:https://www.kanzhiwang.com/archives/13903

我要点评 请您把投稿经验分享出来 让大家少走弯路少踩坑,我为人人、人人为我。

内容纠错 您如果发现杂志信息有错漏 可以在下方留言。

上一篇 2024年10月21日 下午8:42
下一篇 2024年10月21日 下午8:42

相关推荐

发表回复

登录后才能评论

联系我们

191 1833 1195

在线咨询: QQ交谈

邮件:321628655@qq.com

工作时间:周一至周五,9:30-18:30,节假日休息